Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

10.9%

12.8¢ percheron therapeutics limited

Ann: Allowance of Canadian Patent on ATL1103 & Development Update, page-29

First 29 Last

Share
Profile

Follow
itsagas

13,458 Posts.

1442

07/07/14

19:00

Post #: 13623978
Share

Originally posted by kpkg ↑

lol I think I will run with what the Chief said earlier......
Chief Investigator for this study, Dr Peter Trainer, Professor of Endocrinology, The Christie NHS Foundation Trust, UK, said: “The reduction in sIGF-I observed at the 400 mg dose in this small number of patients is most encouraging and supports the continuing recruitment of patients into the study and also indicates the potential to explore higher dosages and different dosing schedules in future clinical trials to optimize ATL1103 usage.”
Maybe as Sammy said it was to explore a higher dose as previously indicated ,either that or they might have found 2 really skinny acromegalics!
"International application PCT/AU2013/000095 has been lodged covering the use of ATL1103 in combination with the GHr antagonist Somavert, for the treatment of acromegaly and cancer."
I dont know but gee wiz that ties in nicely with Pfizer who some believe were the ones doing the due diligence previously (before talks were halted pending the results of the current phase2).

Expand

Good post KP....spot on...

ANP Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

There are more pages in this discussion • 4 more messages in this thread...

First 29 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 12.8¢		Change 0.013(10.9%)		Mkt cap ! $112.6M

Open	High	Low	Value	Volume
12.0¢	13.5¢	12.0¢	$449.9K	3.589M

Buyers (Bids)

No.	Vol.	Price($)
3	1426408	12.5¢

Sellers (Offers)

Price($)	Vol.	No.
13.0¢	462863	7

View Market Depth

No.	Vol.	Price($)
3	1426408	0.125
9	80892	0.120
5	1062411	0.115
5	74098	0.110
3	459523	0.105

Price($)	Vol.	No.
0.130	462863	7
0.135	686443	4
0.140	500000	5
0.145	130461	4
0.150	899746	7

Last trade - 15.04pm 11/10/2024 (20 minute delay)

PER (ASX) Chart